The South Indian Bank Limited
Updates
The South Indian Bank Limited has revised its Marginal Cost of Funds Based Lending Rates (MCLR) for various tenors, effective July 20, 2026.
BSE & NSE corporate filings with AI summaries
The South Indian Bank Limited
The South Indian Bank Limited has revised its Marginal Cost of Funds Based Lending Rates (MCLR) for various tenors, effective July 20, 2026.
Bhansali Engineering Polymers Limited
Bhansali Engineering Polymers Limited has submitted its un-audited financial results for the quarter ended June 30, 2026, and declared an interim dividend of Re.1/- (100%) per equity share. The company has also fixed July 23, 2026, as the record date for determining entitlements of shareholders to receive the dividend.
Rossari Biotech Limited
Rossari Biotech Limited has announced the outcome of its Board meeting, which approved unaudited financial results for the quarter ended June 30, 2026, grant of options under the Rossari Employee Stock Option Plan - 2019, allotment of equity shares under the same plan, and transfer of 100% shareholding of Rossari International Limited Company to Rossari (Singapore) Pte. Ltd.
Shreyans Industries Limited
Shreyans Industries Limited has informed the Exchange that the Record Date for the purpose of Dividend is 05-Aug-2026.
Rossari Biotech Limited
Rossari Biotech Limited has announced the grant of 4000 options under Rossari Employee Stock Option Plan - 2019, allotment of 2500 equity shares, and transfer of 100% shareholding of Rossari International Limited Company to Rossari (Singapore) Pte. Ltd.
Alphageo (India) Limited
Alphageo (India) Limited has informed the Exchange about a copy of newspaper publication regarding the transfer of equity shares to the Investor Education and Protection Fund (IEPF) Account due to unclaimed dividends.
Anuh Pharma Limited
Anuh Pharma Limited has informed the Exchange about the publication of a newspaper advertisement regarding the Notice of the 66th Annual General Meeting, Book Closure, and e-voting information.
Sangam (India) Limited
Sangam (India) Limited has announced the outcome of its board meeting, where it approved the unaudited financial results for the quarter ended June 30, 2026, and the issuance of up to 18,00,000 warrants convertible into equity shares on a preferential basis to the promoter/promoter group at Rs. 555.56 per warrant, aggregating up to Rs. 100,00,08,000. The company also approved a capital expenditure of Rs. 1500 Crores on an expansion project.
HCL Technologies Limited
HCL Technologies Limited has informed the Exchange about Copy of Newspaper Publication, enclosing copies of newspaper advertisements published in English and Hindi newspaper, and making them available on the company's website.
Shreyans Industries Limited
Shreyans Industries Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 12, 2026, to consider and pass various resolutions, including appointment of a new Chairman & Managing Director, re-appointment of a director, and ratification of the appointment of Cost Auditors.
Rossari Biotech Limited
Rossari Biotech Limited has announced the allotment of 2500 equity shares under the Rossari Employee Stock Option Plan - 2019, and the transfer of 100% shareholding of Rossari International Limited Company to Rossari (Singapore) Pte. Ltd. as part of an internal group restructuring exercise.
Sangam (India) Limited
Sangam (India) Limited has submitted its unaudited financial results for the quarter ended June 30, 2026. The company has also announced a preferential issue of up to 18,00,000 warrants convertible into equity shares at a face value of Rs. 10/- per share, aggregating up to Rs. 100,00,08,000/-, to be issued to promoters/promoter group at an issue price of Rs. 555.56/- per warrant. Additionally, the company has approved a capital expenditure of Rs. 1500 Crores (Approx) on an expansion project.
Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company Limited has submitted a copy of the newspaper publication regarding the notice of its 18th Annual General Meeting (AGM) and information on e-voting.
Natco Pharma Limited
Natco Pharma Limited has received tentative approval from the US FDA for its Olaparib tablets, a generic version of AstraZeneca's Lynparza, for the indication in the approved labelling.
C.E. Info Systems Limited
C.E. Info Systems Limited, also known as MapmyIndia, has announced the notice of its 31st Annual General Meeting (AGM) to be held on August 11, 2026, through video conferencing or other audio-visual means. The meeting will consider the ordinary and special businesses as set out in the notice and the annual report for the financial year 2025-26.
ICICI Bank Limited
ICICI Bank Limited has informed the Exchange about Investor Presentation for Q1-2027 financial results.
Rossari Biotech Limited
Rossari Biotech Limited has announced the outcome of its board meeting, which approved unaudited financial results for the quarter ended June 30, 2026, grant of options under the Rossari Employee Stock Option Plan - 2019, allotment of equity shares under the same plan, and transfer of 100% shareholding of Rossari International Limited to Rossari (Singapore) Pte. Ltd.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about letters sent to Shareholders regarding the Annual Report 2025-26 and the 33rd Annual General Meeting (AGM) scheduled for August 11, 2026.
Viyash Scientific Limited
Viyash Scientific Limited has informed the Exchange about the publication of a newspaper advertisement regarding the 41st Annual General Meeting scheduled to be held on August 11, 2026.
Eveready Industries India Limited
Eveready Industries India Limited has published a newspaper advertisement regarding the 91st Annual General Meeting, e-Voting Information and Book Closure, as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.